HIV-1 induces NALP3-inflammasome expression and interleukin-1β secretion in dendritic cells from healthy individuals but not from HIV-positive patients
Authors:
- Alessandra PontilloAPAlessandra Pontillo
- Lais T. SilvaLSLais T. Silva
- Telma M. OshiroTOTelma M. Oshiro
- Claudia FinazzoCFClaudia Finazzo
- Sergio CrovellaSCSergio Crovella
- Alberto J.S. DuarteADAlberto J.S. Duarte
- 2 January 2012
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 26 (1) , 11-18
Abstract
NALP3-inflammasome is an innate mechanism, alternative to type-1 interferon, which is able to recognize nucleic acids and viruses in the cytoplasm and to induce pro-inflammatory response. Here, we hypothesized the involvement of inflammasome in the early defense against HIV-1 and in the full maturation of dendritic cells: for this, we evaluated the response of dendritic cells pulsed with HIV-1 in terms of inflammasome activation in healthy donors. Moreover, inflammasome response to HIV was evaluated in HIV-infected individuals. Monocyte-derived dendritic cells isolated from 20 healthy individuals (HC-DC) and 20 HIV-1-infected patients (HIV-DC) were pulsed with alditrithiol-2-inactivated HIV-1. We then analyzed inflammasome genes expression and interleukin-1β (IL-1β) secretion. In HC-DC, HIV-1 induced higher NLRP3/NALP3 mRNA expression compared with other inflammasome genes such as NALP1/NLRP1 or IPAF/NLRC4 (P < 0.001). This augmented expression was accompanied by CASP1-increased and IL1B-increased mRNA levels and by a significant increment of IL-1β secretion (P < 0.05). Otherwise, HIV-1 failed to activate inflammasome and cytokine production in HIV-DC. HIV-DC showed an increased NLRP3/NALP3 basal expression, suggesting a chronic inflammatory profile of patients’ immune cells. HIV-1 was able to induce a NALP3-inflammasome response in healthy individuals, indicating that this inflammasome could play a role in the first steps of HIV-1 infection; the consequent inflammatory process may be important for directing host immune response against the virus and/or disease progression. HIV-DC seemed to be chronically activated, but unresponsive against pathogens. Our findings could be of interest considering the ongoing research about dendritic cell manipulation and therapeutic strategies for AIDS involving dendritic cell-based immune-vaccines.Keywords
This publication has 16 references indexed in Scilit:
- Central roles of NLRs and inflammasomes in viral infectionNature Reviews Immunology, 2010
- HIV vaccine acceptability: a systematic review and meta-analysisAIDS, 2010
- A 3′UTR SNP in NLRP3 Gene is Associated With Susceptibility to HIV-1 InfectionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Innate immune recognition and activation during HIV infectionRetrovirology, 2010
- Two SNPs inNLRP3gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast BrazilAutoimmunity, 2010
- The InflammasomesCell, 2010
- The immune response during acute HIV-1 infection: clues for vaccine developmentNature Reviews Immunology, 2009
- Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndromeAmerican Journal of Obstetrics and Gynecology, 2009
- Immune activation and inflammation in HIV‐1 infection: causes and consequencesThe Journal of Pathology, 2007
- Therapeutic dendritic-cell vaccine for chronic HIV-1 infectionNature Medicine, 2004